null

SMILES: CNS(=O)(=O)c1cc(cc2CN([C@@H](C)C3CC3)C(=O)c12)-c1sc(Nc2cccc(n2)N2CCN(CCO)CC2=O)nc1C

InChI Key: InChIKey=RNKHOYDAZIEJFF-SFHVURJKSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 489286   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human))	BDBM489286 (2-[(1S)-1-Cyclopropylethyl]-6-[2-({6-[4-(2-hydroxy...) Show SMILES CNS(=O)(=O)c1cc(cc2CN([C@@H](C)C3CC3)C(=O)c12)-c1sc(Nc2cccc(n2)N2CCN(CCO)CC2=O)nc1C |r| Show InChI InChI=1S/C29H35N7O5S2/c1-17-27(20-13-21-15-36(18(2)19-7-8-19)28(39)26(21)22(14-20)43(40,41)30-3)42-29(31-17)33-23-5-4-6-24(32-23)35-10-9-34(11-12-37)16-25(35)38/h4-6,13-14,18-19,30,37H,7-12,15-16H2,1-3H3,(H,31,32,33)/t18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.700	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca AB US Patent					Assay Description The activity of recombinant human PI3Kγ ((aa144-1102)-6His) and PI3Kα, β, δ (6-His(p110-p85α)) was determined by measuring t...				US Patent US10961236 (2021)
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (Homo sapiens (Human))	BDBM489286 (2-[(1S)-1-Cyclopropylethyl]-6-[2-({6-[4-(2-hydroxy...) Show SMILES CNS(=O)(=O)c1cc(cc2CN([C@@H](C)C3CC3)C(=O)c12)-c1sc(Nc2cccc(n2)N2CCN(CCO)CC2=O)nc1C |r| Show InChI InChI=1S/C29H35N7O5S2/c1-17-27(20-13-21-15-36(18(2)19-7-8-19)28(39)26(21)22(14-20)43(40,41)30-3)42-29(31-17)33-23-5-4-6-24(32-23)35-10-9-34(11-12-37)16-25(35)38/h4-6,13-14,18-19,30,37H,7-12,15-16H2,1-3H3,(H,31,32,33)/t18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	481	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca AB US Patent					Assay Description The activity of recombinant human PI3Kγ ((aa144-1102)-6His) and PI3Kα, β, δ (6-His(p110-p85α)) was determined by measuring t...				US Patent US10961236 (2021)
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Homo sapiens (Human))	BDBM489286 (2-[(1S)-1-Cyclopropylethyl]-6-[2-({6-[4-(2-hydroxy...) Show SMILES CNS(=O)(=O)c1cc(cc2CN([C@@H](C)C3CC3)C(=O)c12)-c1sc(Nc2cccc(n2)N2CCN(CCO)CC2=O)nc1C |r| Show InChI InChI=1S/C29H35N7O5S2/c1-17-27(20-13-21-15-36(18(2)19-7-8-19)28(39)26(21)22(14-20)43(40,41)30-3)42-29(31-17)33-23-5-4-6-24(32-23)35-10-9-34(11-12-37)16-25(35)38/h4-6,13-14,18-19,30,37H,7-12,15-16H2,1-3H3,(H,31,32,33)/t18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	27	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca AB US Patent					Assay Description The activity of recombinant human PI3Kγ ((aa144-1102)-6His) and PI3Kα, β, δ (6-His(p110-p85α)) was determined by measuring t...				US Patent US10961236 (2021)
					More data for this Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [144-1102] (Homo sapiens (Human))	BDBM489286 (2-[(1S)-1-Cyclopropylethyl]-6-[2-({6-[4-(2-hydroxy...) Show SMILES CNS(=O)(=O)c1cc(cc2CN([C@@H](C)C3CC3)C(=O)c12)-c1sc(Nc2cccc(n2)N2CCN(CCO)CC2=O)nc1C |r| Show InChI InChI=1S/C29H35N7O5S2/c1-17-27(20-13-21-15-36(18(2)19-7-8-19)28(39)26(21)22(14-20)43(40,41)30-3)42-29(31-17)33-23-5-4-6-24(32-23)35-10-9-34(11-12-37)16-25(35)38/h4-6,13-14,18-19,30,37H,7-12,15-16H2,1-3H3,(H,31,32,33)/t18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.900	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca AB US Patent					Assay Description The activity of recombinant human PI3Kγ ((aa144-1102)-6His) and PI3Kα, β, δ (6-His(p110-p85α)) was determined by measuring t...				US Patent US10961236 (2021)
					More data for this Ligand-Target Pair